Fluoropyrimidines as Antifolate Drugs
- 1 January 1999
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 93 references indexed in Scilit:
- 1096: Bolus injection versus short-term infusion of 5-fluorouracil in patients with advanced colorectal cancer: A prospective randomized trialEuropean Journal Of Cancer, 1997
- 755: A phase II trial of trimetrexate (TMTX), 5-fluorouracil (5-FU) and folinic acid (FA) in untreated patients with advanced colorectal carcinomaEuropean Journal Of Cancer, 1997
- Biochemical mechanisms of interferon modulation of 5-fluorouracil activity in colon cancer cellsEuropean Journal Of Cancer, 1997
- Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancerEuropean Journal Of Cancer, 1997
- Efficacy of oral tegafur modulation by uracil and leucovorin in advanced colorectal cancer. A phase II studyEuropean Journal Of Cancer, 1995
- Modulation of the antitumour activity of cisplatin alone and in combination with 5-fluoro-2'-deoxyuridine by N-phosphonacetyl-l-aspartate in murine colon carcinoma no. 26European Journal Of Cancer, 1995
- Effects of the modulating agent WR2721 on myelotoxicity and antitumour activity in carboplatin-treated miceEuropean Journal Of Cancer, 1994
- Treatment of advanced colorectal cancer with folinic acid and 5-fluorouracil in combination with cisplatinumEuropean Journal Of Cancer, 1994
- Biochemical modification of the toxicity and the anti-tumour effect of 5-fluorouracil and cis-platinum by WR-2721 in miceEuropean Journal Of Cancer, 1992
- Fluorinated Pyrimidines, A New Class of Tumour-Inhibitory CompoundsNature, 1957